Vistin Pharma ASA (OSL:VISTN)
Norway
· Delayed Price · Currency is NOK 22.80
+0.10 (0.44%)
At close: Apr 28, 2026
Vistin Pharma ASA Balance Sheet
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 6.33 | 16.42 | 12.79 | 26.2 | 1.44 | 35.75 | Upgrade
|
| Cash & Short-Term Investments | 6.33 | 16.42 | 12.79 | 26.2 | 1.44 | 35.75 | Upgrade
|
| Cash Growth | -50.04% | 28.33% | -51.18% | 1726.06% | -95.99% | -53.60% | Upgrade
|
| Accounts Receivable | 100.16 | 89.71 | 44.28 | 47.02 | 66.16 | 40.25 | Upgrade
|
| Other Receivables | 28.12 | 15.26 | 7.7 | 12.56 | 5.01 | 2.85 | Upgrade
|
| Receivables | 128.28 | 104.97 | 51.98 | 59.59 | 71.17 | 43.09 | Upgrade
|
| Inventory | 82.93 | 82.13 | 76.67 | 80.17 | 83.45 | 42.91 | Upgrade
|
| Prepaid Expenses | - | - | 1.75 | 2.81 | 3.14 | 16.09 | Upgrade
|
| Other Current Assets | -0 | 0 | - | - | - | - | Upgrade
|
| Total Current Assets | 217.54 | 203.52 | 143.19 | 168.77 | 159.18 | 137.83 | Upgrade
|
| Property, Plant & Equipment | 223.87 | 223.75 | 229.6 | 219.98 | 219.43 | 167.46 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | - | 14.64 | 28.6 | 27.86 | Upgrade
|
| Other Long-Term Assets | 12.15 | 12.15 | 12.16 | - | - | 0 | Upgrade
|
| Total Assets | 453.56 | 439.43 | 384.95 | 403.4 | 407.21 | 333.15 | Upgrade
|
| Accounts Payable | 25.41 | 30.24 | 13.05 | 18.92 | 25.91 | 20.81 | Upgrade
|
| Accrued Expenses | - | - | 15.82 | 16.59 | 14.67 | 16.58 | Upgrade
|
| Short-Term Debt | - | - | - | - | 45.14 | - | Upgrade
|
| Current Portion of Leases | - | 0.88 | - | - | 1.07 | 0.88 | Upgrade
|
| Other Current Liabilities | 48.11 | 47.87 | 35.1 | 33.96 | 30.78 | 2.78 | Upgrade
|
| Total Current Liabilities | 73.52 | 78.99 | 63.97 | 69.47 | 117.57 | 41.04 | Upgrade
|
| Long-Term Leases | 0.5 | 0.62 | 1.33 | - | 2.96 | 0.51 | Upgrade
|
| Pension & Post-Retirement Benefits | 6.31 | 6.42 | 6.6 | 8.86 | 13.2 | 15.83 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 22.93 | 24.59 | 3.52 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | -0 | - | 0 | 2.29 | -0 | 0 | Upgrade
|
| Total Liabilities | 103.25 | 110.61 | 75.42 | 80.63 | 133.73 | 57.38 | Upgrade
|
| Common Stock | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 | 44.35 | Upgrade
|
| Additional Paid-In Capital | 73.87 | 73.87 | 129.3 | 206.89 | 206.89 | 206.89 | Upgrade
|
| Retained Earnings | 232.09 | 210.61 | 135.89 | 71.54 | 22.26 | 24.54 | Upgrade
|
| Comprehensive Income & Other | 0 | - | - | - | - | - | Upgrade
|
| Shareholders' Equity | 350.31 | 328.82 | 309.53 | 322.77 | 273.49 | 275.77 | Upgrade
|
| Total Liabilities & Equity | 453.56 | 439.43 | 384.95 | 403.4 | 407.21 | 333.15 | Upgrade
|
| Total Debt | 0.5 | 1.5 | 1.33 | - | 49.17 | 1.39 | Upgrade
|
| Net Cash (Debt) | 5.83 | 14.92 | 11.47 | 26.2 | -47.73 | 34.36 | Upgrade
|
| Net Cash Growth | -45.38% | 30.09% | -56.24% | - | - | -55.40% | Upgrade
|
| Net Cash Per Share | 0.13 | 0.34 | 0.26 | 0.59 | -1.08 | 0.77 | Upgrade
|
| Filing Date Shares Outstanding | 44.44 | 44.34 | 44.34 | 44.34 | 44.34 | 44.34 | Upgrade
|
| Total Common Shares Outstanding | 44.44 | 44.34 | 44.34 | 44.34 | 44.34 | 44.34 | Upgrade
|
| Working Capital | 144.02 | 124.54 | 79.22 | 99.3 | 41.61 | 96.8 | Upgrade
|
| Book Value Per Share | 7.88 | 7.42 | 6.98 | 7.28 | 6.17 | 6.22 | Upgrade
|
| Tangible Book Value | 350.31 | 328.82 | 309.53 | 322.77 | 273.49 | 275.77 | Upgrade
|
| Tangible Book Value Per Share | 7.88 | 7.42 | 6.98 | 7.28 | 6.17 | 6.22 | Upgrade
|
| Machinery | - | - | 268.64 | 263.53 | 253.37 | - | Upgrade
|
| Construction In Progress | - | - | 39.09 | 17.91 | 10.24 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.